ACADIAN ASSET MANAGEMENT LLC - EAGLE PHARMACEUTICALS INC ownership

EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 109 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.93 and the average weighting 0.0%.

Quarter-by-quarter ownership
ACADIAN ASSET MANAGEMENT LLC ownership history of EAGLE PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$3,733
-14.4%
236,902
+5.5%
0.02%
-11.1%
Q2 2023$4,361
-28.6%
224,576
+4.2%
0.02%
-33.3%
Q1 2023$6,108
-9.7%
215,431
-7.0%
0.03%
-18.2%
Q4 2022$6,765
-99.9%
231,587
-25.6%
0.03%
-26.7%
Q3 2022$8,223,000
-1.0%
311,220
+66.5%
0.04%
+7.1%
Q2 2022$8,303,000
+20.2%
186,873
+33.8%
0.04%
+50.0%
Q1 2022$6,908,000
+28.2%
139,695
+31.9%
0.03%
+40.0%
Q4 2021$5,388,000
-25.3%
105,879
-18.2%
0.02%
-28.6%
Q3 2021$7,213,000
-35.6%
129,430
-50.5%
0.03%
-33.3%
Q2 2021$11,200,000
+26.0%
261,703
+22.9%
0.04%
+20.0%
Q1 2021$8,890,000
+11.3%
213,009
+24.2%
0.04%
+12.9%
Q4 2020$7,988,000
+11.5%
171,484
+1.7%
0.03%
+3.3%
Q3 2020$7,167,000
+26.5%
168,699
+42.9%
0.03%
+25.0%
Q2 2020$5,664,000
+39.9%
118,056
+34.1%
0.02%
+4.3%
Q1 2020$4,049,000
+185.5%
88,013
+272.9%
0.02%
+283.3%
Q4 2019$1,418,000
-17.8%
23,600
-22.6%
0.01%
-14.3%
Q3 2019$1,725,000
-11.1%
30,493
-12.6%
0.01%
-22.2%
Q2 2019$1,941,000
+824.3%
34,873
+740.7%
0.01%
+800.0%
Q1 2019$210,000
+73.6%
4,148
+37.9%
0.00%0.0%
Q4 2018$121,000
+5.2%
3,008
+82.1%
0.00%
Q3 2018$115,000
-42.8%
1,652
-56.1%
0.00%
-100.0%
Q4 2017$201,000
-55.9%
3,761
-50.8%
0.00%
-50.0%
Q3 2017$456,0007,6370.00%
Other shareholders
EAGLE PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
JW Asset Management, LLC 475,755$25,068,00024.71%
Hudson Executive Capital LP 971,000$51,162,00015.09%
Park West Asset Management LLC 1,051,274$55,392,0002.47%
U S GLOBAL INVESTORS INC 19,200$1,012,0000.62%
Capital Impact Advisors, LLC 26,317$1,387,0000.57%
CLARK ESTATES INC/NY 56,278$2,965,0000.47%
IRIDIAN ASSET MANAGEMENT LLC/CT 873,131$46,005,0000.41%
ProQuest Associates IV LLC 6,777$357,0000.41%
Granite Investment Partners, LLC 114,207$6,017,0000.40%
GLOBEFLEX CAPITAL L P 30,900$1,628,0000.34%
View complete list of EAGLE PHARMACEUTICALS INC shareholders